Table 4.
The subgroup analysis for clinical outcome of aSAH patients.
| Variables | n (%) | TyG-i > 8.804 | TyG-i ≤ 8.804 | OR (95%CI) | p | p for interaction |
|---|---|---|---|---|---|---|
| All patients | 467 (100.00) | 165/233 | 199/234 | 2.34 (1.48–3.70) | <0.001 | |
| Gender | 0.113 | |||||
| Female | 277 (59.31) | 96/140 | 120/137 | 3.24 (1.74–6.02) | <0.001 | |
| Male | 190 (40.69) | 69/93 | 79/97 | 1.53 (0.76–3.05) | 0.230 | |
| Age older than 65 years | 0.618 | |||||
| No | 360 (77.09) | 139/181 | 158/179 | 2.27 (1.28–4.03) | 0.005 | |
| Yes | 107 (22.91) | 26/52 | 41/55 | 2.93 (1.30–6.61) | 0.010 | |
| Graeb score | 0.406 | |||||
| 0–4 | 433 (92.72) | 156/210 | 191/223 | 2.07 (1.27–3.36) | 0.003 | |
| 5–12 | 34 (7.28) | 9/23 | 8/11 | 4.15 (0.86–19.92) | 0.076 | |
| SEBES score | 0.896 | |||||
| 0–2 | 249 (53.32) | 88/127 | 103/122 | 2.40 (1.30–4.46) | 0.005 | |
| 3–4 | 218 (46.68) | 77/106 | 96/112 | 2.26 (1.14–4.46) | 0.019 | |
| mFS Score | 0.421 | |||||
| 0–2 | 169 (36.19) | 62/76 | 82/93 | 1.68 (0.72–3.96) | 0.233 | |
| 3–4 | 298 (63.81) | 103/157 | 117/141 | 2.56 (1.48–4.43) | <0.001 | |
| WFNS score | 0.225 | |||||
| 1–3 | 361 (77.30) | 141/174 | 174/187 | 3.13 (1.59–6.18) | <0.001 | |
| 4–5 | 106 (22.70) | 24/59 | 25/47 | 1.66 (0.76–3.59) | 0.200 | |
| Hunt Hess score | 0.156 | |||||
| 1–3 | 420 (89.94) | 158/207 | 193/213 | 2.99 (1.71–5.24) | <0.001 | |
| 4–5 | 47 (10.06) | 7/26 | 6/21 | 1.09 (0.30–3.92) | 0.900 | |
| IVH | 0.860 | |||||
| No | 187 (40.04) | 70/84 | 94/103 | 2.09 (0.86–5.10) | 0.106 | |
| Yes | 280 (59.96) | 95/149 | 105/131 | 2.30 (1.33–3.95) | 0.003 | |
| Loss of consciousness | 0.187 | |||||
| No | 322 (68.95) | 123/153 | 157/169 | 3.19 (1.57–6.49) | 0.001 | |
| Yes | 145 (31.05) | 42/80 | 42/65 | 1.65 (0.84–3.23) | 0.143 | |
| Treatment modality | 0.714 | |||||
| Endovascular intervention | 213 (45.61) | 85/110 | 93/103 | 2.74 (1.24–6.03) | 0.013 | |
| Surgical clipping | 254 (54.39) | 80/123 | 106/131 | 2.28 (1.29–4.04) | 0.005 | |
| Current smoking | 0.270 | |||||
| No | 387 (82.87) | 133/186 | 169/201 | 2.10 (1.28–3.45) | 0.003 | |
| Yes | 80 (17.13) | 32/47 | 30/33 | 4.69 (1.23–17.82) | 0.023 | |
| Current drinking | 0.786 | |||||
| No | 416 (89.08) | 147/204 | 181/212 | 2.26 (1.39–3.69) | 0.001 | |
| Yes | 51 (10.92) | 18/29 | 18/22 | 2.75 (0.74–10.27) | 0.132 | |
| Diabetes | 0.376 | |||||
| No | 441 (94.43) | 154/216 | 193/225 | 2.43 (1.51–3.91) | <0.001 | |
| Yes | 26 (5.57) | 11/17 | 6/9 | 1.09 (0.20–6.01) | 0.920 | |
| Hypertension | 0.472 | |||||
| No | 222 (47.54) | 74/92 | 114/130 | 1.73 (0.83–3.61) | 0.142 | |
| Yes | 245 (52.46) | 91/141 | 85/104 | 2.46 (1.34–4.50) | 0.004 | |
| History of heart disease | 0.886 | |||||
| No | 401 (85.87) | 146/194 | 181/207 | 2.29 (1.35–3.87) | 0.002 | |
| Yes | 66 (14.13) | 19/39 | 18/27 | 2.11 (0.76–5.82) | 0.151 | |
| History of anticoagulant | 0.694 | |||||
| No | 454 (97.22) | 161/226 | 195/228 | 2.39 (1.49–3.81) | <0.001 | |
| Yes | 13 (2.78) | 4/7 | 4/6 | 1.50 (0.16–14.42) | 0.725 |
OR, Odds Ratio, CI, Confidence Interval, mFS, modified Fisher scale; SEBES, Subarachnoid Hemorrhage Early Brain Edema Score; IVH, intraventricular hemorrhage; GCS, Glasgow coma score; WFNS, World Federation of Neurological Societies. Bold values: p < 0.05.